Burkitt lymphoma · 2 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
CVP Variant #01 | — | R 613 | 21d | — | — | ~8 | ~R 4 901 indirect | — |
Cyclophosphamide and Prednisone Variant #02 | — | R 17 | — | — | ~10.0 mo | ~1 | ~R 17 PFS proxy · indirect | 1 |
2 of 2 regimens shown